Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China
This protocol was developed to conduct population-wide surveillance of the bivalent HPV-16/18-AS04-adjuvanted human papillomavirus (HPV) vaccine in terms of uptake and safety outcomes including potential immune-mediated diseases (pIMDs) and pregnancy-related outcomes in China. The study will use ele...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
格式: | Article |
語言: | English |
出版: |
Taylor & Francis Group
2024-12-01
|
叢編: | Human Vaccines & Immunotherapeutics |
主題: | |
在線閱讀: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2378535 |